Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
GlobeNewswire, Inc.
Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered by GENFIT’s proprietary NIS4® technology Focuses on patients at highest risk, including those with...
VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 02, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for its lead BiTAC® T-cell engager (BiTAC-TCE)...
Anaveon Appoints Laetitia Pouzol as Chief Scientific Officer
GlobeNewswire, Inc.
BASEL, Switzerland, July 02, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today announced the...
Bitcoin Suisse Moves Its Ethereum Staking to Obol Distributed Validators
EIN Presswire
Switzerland's native premium crypto financial service provider is transitioning to operating its Ethereum validators on Obol Distributed Validators.
Secro Appoints Guy de Pourtalès As Chief Technology Officer
EIN Presswire
Strengthening SECRO’s bank-grade digital infrastructure, scalability, and AI roadmap for global trade finance documentation GENEVA, SWITZERLAND, July 1, 2026 /EINPresswire.com/ -- SECRO, the trade finance tokenization and document workflow...
Parametric Insurance Market to Reach $34.4 Billion Globally by 2033, Growing at 6.6% CAGR | Allied Market Research
EIN Presswire
Rising Climate Risks, Rapid Claims Processing, AI-Driven Risk Modeling, and Expanding Alternative Risk Transfer Solutions Accelerate Global Market Growth WILMINGTON, DE, UNITED STATES, July 1, 2026 /EINPresswire.com/ -- According to a new report...
Natural Embrace™ Introduces Made in USA High-Tech Skincare for Sensitive Skin
EIN Presswire
LOS ANGELES, CA, UNITED STATES, June 30, 2026 /EINPresswire.com/ -- Natural Embrace™, a USA-based skincare company focused on advanced skin science and natural ingredients, is pleased to announce the introduction of its Made in USA skincare and...
Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM
GlobeNewswire, Inc.
- Acoramidis initiation was associated with rapid kidney-protective activity as exhibited in a hemodynamically mediated, reversible eGFR dip and a placebo-corrected 15.5% reduction in UACR by Day 28 (P<0.05), with no kidney-related adverse events...
AB Science reports completion of the step 3 of phase 1, evaluating the combination of AB8939 with venetoclax for the treatment of refractory or relapsed AML
GlobeNewswire, Inc.
PRESS RELEASE AB SCIENCE REPORTS COMPLETION OF THE STEP 3 OF PHASE 1, EVALUATING THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA THE COMBINATION OF AB8939 WITH VENETOCLAX GENERATED A 67%...
Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference
GlobeNewswire, Inc.
ZUG, Switzerland, July 02, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with...
CTModule Launches Callisto AI to Extend its Leading UCC Solution with Intelligent Voice Automation
EIN Presswire
BüMPLIZ, SWITZERLAND, July 2, 2026 /EINPresswire.com/ -- CTModule AG has launched Callisto AI, a new AI layer within its Callisto Unified Communications and Collaboration platform, designed to bring intelligent automation into enterprise...
Beauty&Longevity CHOICE Awards 2027 Open for Entries, Putting Science-Led Beauty & Longevity Innovation in the Spotlight
EIN Presswire
19 categories across four pillars—from skin longevity and metabolic health to diagnostics, devices and biotech.
AMERICAN SWISS FOUNDATION HOSTS 2026 LEADERSHIP SUMMIT IN RÜSCHLIKON, SWITZERLAND
EIN Presswire
"U.S.–Swiss Leadership in Technological Advancements” RÜSCHLIKON, ZÜRICH, SWITZERLAND, June 26, 2026 /EINPresswire.com/ -- On June 16–17, 2026, the American Swiss Foundation convened its annual Leadership Summit at the Swiss Re Centre for Global...
Switzerland ERP Industry Expands at 11.0% CAGR, Eyeing $1,272.14 Million by 2030 | AMR
EIN Presswire
WILMINGTON, NEW CASTLE, DE, UNITED STATES, June 24, 2026 /EINPresswire.com/ -- According to a recent report published by Allied Market Research, titled, "Switzerland ERP Market by Component, deployment model, business function, end user and...
Microshare®, Taqt and Zurich Airport announce digital transformation partnership for global airport terminal operations
EIN Presswire
Microshare has launched a partnership with Zurich Airport and device maker Taqt to expand globally its model of integrated, data-driven terminal operations.
Forward Edge-AI, Inc. and Forward Edge-AI, India Private Limited Unveil Vision for U.S.-India Deep Technology Alliance
EIN Presswire
A Strategic Partnership Advancing Deep-Tech in India SAN ANTONIO, TX, UNITED STATES, June 25, 2026 /EINPresswire.com/ -- Forward Edge-AI, Inc. and Forward Edge-AI India Private Limited today unveiled a shared vision for a next-generation...
Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)
GlobeNewswire, Inc.
Under Veripure, Provectus is supplying qualified medical researchers with the same pharmaceutical grade rose bengal sodium API used in clinical trials.
VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – June 24, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced that the Company has moved into additional laboratory space at its existing R&D site in...
Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712
GlobeNewswire, Inc.
Five sites recruiting in US study of DLL3-targeting 212Pb-labelled Radio-DARPin MP0712 Dosing ongoing in first patients, consecutively moving to subsequent dosing cycles Initial data anticipated within the coming months, comprehensive efficacy...
European Venture Fair Celebrates 25th Anniversary with Exclusive Gathering of Corporate and Venture Investors in Zurich
GlobeNewswire, Inc.
ZURICH, June 24, 2026 (GLOBE NEWSWIRE) -- The European Venture Fair (EVF), one of Europe's longest-running investor gatherings, will celebrate its 25th anniversary on September 9-10, 2026, bringing together ~150 corporate, institutional, and...
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.